← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 22, 2021Last known activity
Nov 15, 2025
Timeline
2010s
- Jun 1, 2019
Abogen Biosciences Co. Ltd.— Founded
Drugs by trial phase (10 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Recent trials (15)
- NCT07285278CollaboratorPhase 2Nov 15, 2025
- NCT07285278Lead sponsorPhase 2Nov 15, 2025
- NCT07289542Lead sponsorPhase 2Sep 15, 2025
- NCT07289542CollaboratorPhase 2Sep 15, 2025
- NCT07289503Lead sponsorPhase 1May 27, 2025
- NCT07285265CollaboratorPhase 1May 27, 2025
- NCT07285265Lead sponsorPhase 1May 27, 2025
- NCT07289503CollaboratorPhase 1May 27, 2025
- NCT06577532CollaboratorEarly Phase 1Sep 24, 2024
- NCT06088004Lead sponsorPhase 1Sep 28, 2023
- NCT05636319Lead sponsorPhase 2/Phase 3Nov 23, 2022
- NCT05433194Lead sponsorPhase 1Aug 22, 2022
- NCT05434585Study directorPhase 1Jul 8, 2022
- NCT05434585Lead sponsorPhase 1Jul 8, 2022
- NCT04847102CollaboratorPhase 3Jul 22, 2021
Details
- Founded
- Suzhou, CN Jun 1, 2019
- Last known activity
- Nov 15, 2025